Literature DB >> 10639345

Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro.

J E Bina1, R A Alm, M Uria-Nickelsen, S R Thomas, T J Trust, R E Hancock.   

Abstract

We previously demonstrated (M. M. Exner, P. Doig, T. J. Trust, and R. E. W. Hancock, Infect. Immun. 63:1567-1572, 1995) that Helicobacter pylori has at least one nonspecific porin, HopE, which has a low abundance in the outer membrane but forms large channels. H. pylori is relatively susceptible to most antimicrobial agents but less susceptible to the polycationic antibiotic polymyxin B. We demonstrate here that H. pylori is able to take up higher basal levels of the hydrophobic fluorescent probe 1-N-phenylnaphthylamine (NPN) than Pseudomonas aeruginosa or Escherichia coli, consistent with its enhanced susceptibility to hydrophobic agents. Addition of polymyxin B led to a further increase in NPN uptake, indicative of a self-promoted uptake pathway, but it required a much higher amount of polymyxin B to yield a 50% increase in NPN uptake in H. pylori (6 to 8 microg/ml) than in P. aeruginosa or E. coli (0.3 to 0.5 microg/ml), suggesting that H. pylori has a less efficient self-promoted uptake pathway. Since intrinsic resistance involves the collaboration of restricted outer membrane permeability and secondary defense mechanisms, such as periplasmic beta-lactamase (which H. pylori lacks) or efflux, we examined the possible role of efflux in antibiotic susceptibility. We had previously identified in H. pylori 11637 the presence of portions of three genes with homology to potential restriction-nodulation-division (RND) efflux systems. It was confirmed that H. pylori contained only these three putative RND efflux systems, named here hefABC, hefDEF, and hefGHI, and that the hefGHI system was expressed only in vivo while the two other RND systems were expressed both in vivo and in vitro. In uptake studies, there was no observable energy-dependent tetracycline, chloramphenicol, or NPN efflux activity in H. pylori. Independent mutagenesis of the three putative RND efflux operons in the chromosome of H. pylori had no effect on the in vitro susceptibility of H. pylori to 19 antibiotics. These results, in contrast to what is observed in E. coli, P. aeruginosa, and other clinically important gram-negative bacteria, suggest that active efflux does not play a role in the intrinsic resistance of H. pylori to antibiotics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639345      PMCID: PMC89666          DOI: 10.1128/AAC.44.2.248-254.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  A contig assembly program based on sensitive detection of fragment overlaps.

Authors:  X Huang
Journal:  Genomics       Date:  1992-09       Impact factor: 5.736

2.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

3.  Molecular characterization of cloned avirulence genes from race 0 and race 1 of Pseudomonas syringae pv. glycinea.

Authors:  B Staskawicz; D Dahlbeck; N Keen; C Napoli
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

4.  Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.

Authors:  C A McNulty; J Dent; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

5.  Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport.

Authors:  M H Saier; R Tam; A Reizer; J Reizer
Journal:  Mol Microbiol       Date:  1994-03       Impact factor: 3.501

Review 6.  Treatment of Helicobacter pylori infection: a review of the world literature.

Authors:  R W van der Hulst; J J Keller; E A Rauws; G N Tytgat
Journal:  Helicobacter       Date:  1996-03       Impact factor: 5.753

7.  Cloning of Campylobacter jejuni genes required for leucine biosynthesis, and construction of leu-negative mutant of C. jejuni by shuttle transposon mutagenesis.

Authors:  A Labigne; P Courcoux; L Tompkins
Journal:  Res Microbiol       Date:  1992-01       Impact factor: 3.992

8.  Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.

Authors:  N A Curtis; R L Eisenstadt; C Rudd; A J White
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

9.  Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.

Authors:  R A Alm; L S Ling; D T Moir; B L King; E D Brown; P C Doig; D R Smith; B Noonan; B C Guild; B L deJonge; G Carmel; P J Tummino; A Caruso; M Uria-Nickelsen; D M Mills; C Ives; R Gibson; D Merberg; S D Mills; Q Jiang; D E Taylor; G F Vovis; T J Trust
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

10.  Isolation and characterization of a family of porin proteins from Helicobacter pylori.

Authors:  M M Exner; P Doig; T J Trust; R E Hancock
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more
  48 in total

1.  Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.

Authors:  Li-Hui Wang; Hong Cheng; Fu-Lian Hu; Jiang Li
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France.

Authors:  Magali Garcia; Josette Raymond; Martine Garnier; Julie Cremniter; Christophe Burucoa
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

Review 3.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  Role of the HefC efflux pump in Helicobacter pylori cholesterol-dependent resistance to ceragenins and bile salts.

Authors:  Elizabeth A Trainor; Katherine E Horton; Paul B Savage; Traci L Testerman; David J McGee
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

5.  Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization.

Authors:  Amin Talebi Bezmin Abadi
Journal:  World J Gastroenterol       Date:  2017-09-21       Impact factor: 5.742

Review 6.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 7.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

8.  Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families.

Authors:  R A Alm; J Bina; B M Andrews; P Doig; R E Hancock; T J Trust
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

9.  Quinolone resistance in Helicobacter pylori isolates in Germany.

Authors:  Erik Glocker; Hans-Peter Stueger; Manfred Kist
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

10.  Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  Beilei Ge; Patrick F McDermott; David G White; Jianghong Meng
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.